Chris Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chris Brown has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Chun Shen Lim
University of Otago
11 shared publications - Peter C. Fineran
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
11 shared publications - Chase L. Beisel
Helmholtz Institute for RNA-based Infection Research (HIRI) Helmholtz Center for Infection Research, 97080 Würzburg, Germany
4 shared publications - Nils Birkholz
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
4 shared publications Ambarish Biswas
Department of Biochemistry, University of Otago, PO Box 56, Dunedin, 9054, New Zealand
3 shared publications- Andrew Edwin Firth
Department of Pathology, University of Cambridge , Cambridge, CB2 0QQ
3 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (17)
An expanded realm of anti-CRISPR-associated proteins and regulatory mechanisms
Many bacteriophages encode anti-CRISPR (Acr) proteins that inhibit bacterial CRISPR–Cas immune systems. Rapid acr gene expression upon phage entry enables CRISPR–Cas neutralization but can impact phage fitness if unregulated. Therefore, Acr production is often controlled by distinct families of co-encoded anti-CRISPR-associated (Aca) proteins, which are usually helix-turn-helix (HTH) regulators that bind DNA within acr–aca operon promoters. Previously, we demonstrated that the Aca2 family additionally represses Acr production translationally by binding structured RNA motifs within the 5′ untranslated region (UTR) of the acr–aca mRNA. Here, through systematic bioinformatic analyses, we provide evidence of structured RNA motifs in the 5′ UTRs of operons encoding members of other Aca families and show that Aca1 also specifically binds its cognate RNA motif. Additionally, many Aca proteins are predicted to regulate not only their own but also adjacent operons with potential anti-defence genes. Indeed, we show that Aca14, newly identified in this study, represses two predicted anti-defence operons. Aca14 is a ribbon-helix-helix domain protein, revealing regulatory diversity beyond the canonical HTH Aca family members. Collectively, our findings expand our understanding of acr regulation in mobile genetic elements and reveal novel mechanisms by which phages fine-tune anti-defence gene expression.
- 7 September 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (17)
Open AccessAn expanded realm of anti-CRISPR-associated proteins and regulatory mechanisms
Many bacteriophages encode anti-CRISPR (Acr) proteins that inhibit bacterial CRISPR–Cas immune systems. Rapid acr gene expression upon phage entry enables CRISPR–Cas neutralization but can impact phage fitness if unregulated. Therefore, Acr production is often controlled by distinct families of co-encoded anti-CRISPR-associated (Aca) proteins, which are usually helix-turn-helix (HTH) regulators that bind DNA within acr–aca operon promoters. Previously, we demonstrated that the Aca2 family additionally represses Acr production translationally by binding structured RNA motifs within the 5′ untranslated region (UTR) of the acr–aca mRNA. Here, through systematic bioinformatic analyses, we provide evidence of structured RNA motifs in the 5′ UTRs of operons encoding members of other Aca families and show that Aca1 also specifically binds its cognate RNA motif. Additionally, many Aca proteins are predicted to regulate not only their own but also adjacent operons with potential anti-defence genes. Indeed, we show that Aca14, newly identified in this study, represses two predicted anti-defence operons. Aca14 is a ribbon-helix-helix domain protein, revealing regulatory diversity beyond the canonical HTH Aca family members. Collectively, our findings expand our understanding of acr regulation in mobile genetic elements and reveal novel mechanisms by which phages fine-tune anti-defence gene expression.
- Open Access
An expanded realm of anti-CRISPR-associated proteins and regulatory mechanisms
Many bacteriophages encode anti-CRISPR (Acr) proteins that inhibit the CRISPR-Cas immune systems. Rapid acr gene expression upon phage entry enables CRISPR-Cas neutralisation, but can impact phage fitness if unregulated. Therefore, Acr production is often controlled by distinct families of co-encoded anti-CRISPR-associated (Aca) proteins, which are usually helix-turn-helix (HTH) regulators that bind DNA within acr-aca operon promoters. Previously, we demonstrated that the Aca2 family additionally represses Acr production translationally by binding structured RNA motifs within the 5' untranslated regions (UTRs) of the acr-aca mRNA. Here, through systematic bioinformatic analyses, we provide evidence of structured RNA motifs in the 5' UTRs of operons encoding members of other Aca families, and that Aca1 also specifically binds its cognate RNA motif. Additionally, many Aca proteins are predicted to regulate not only their own but also adjacent operons with potential anti-defence genes. Indeed, we show that Aca14, newly identified in this study, represses two predicted anti-defence operons. Aca14 is a ribbon-helix-helix domain protein, revealing regulatory diversity beyond the canonical HTH Aca family members. Collectively, our findings expand the understanding of acr regulation in mobile genetic elements and reveal novel mechanisms by which phages fine-tune anti-defence gene expression.
Open AccessAn expanded realm of anti-CRISPR-associated proteins and regulatory mechanisms
Many bacteriophages encode anti-CRISPR (Acr) proteins that inhibit the CRISPR-Cas immune systems. Rapid acr gene expression upon phage entry enables CRISPR-Cas neutralisation, but can impact phage fitness if unregulated. Therefore, Acr production is often controlled by distinct families of co-encoded anti-CRISPR-associated (Aca) proteins, which are usually helix-turn-helix (HTH) regulators that bind DNA within acr-aca operon promoters. Previously, we demonstrated that the Aca2 family additionally represses Acr production translationally by binding structured RNA motifs within the 5' untranslated regions (UTRs) of the acr-aca mRNA. Here, through systematic bioinformatic analyses, we provide evidence of structured RNA motifs in the 5' UTRs of operons encoding members of other Aca families, and that Aca1 also specifically binds its cognate RNA motif. Additionally, many Aca proteins are predicted to regulate not only their own but also adjacent operons with potential anti-defence genes. Indeed, we show that Aca14, newly identified in this study, represses two predicted anti-defence operons. Aca14 is a ribbon-helix-helix domain protein, revealing regulatory diversity beyond the canonical HTH Aca family members. Collectively, our findings expand the understanding of acr regulation in mobile genetic elements and reveal novel mechanisms by which phages fine-tune anti-defence gene expression.
- Open Access
Phage-encoded single-guide RNAs subvert CRISPR-Cas9 immunity
Central to CRISPR technologies is the single-guide RNA (sgRNA), an engineered fusion of a processed CRISPR RNA and tracrRNA that directs Cas9 and many Cas12 nucleases to bind and cleave target DNA. Here, we report the discovery of similarly compact viral sgRNAs (vsgRNAs) encoded by bacteriophages that counteract bacterial CRISPR-Cas9 immunity. vsgRNAs inhibit Cas9 function via two complementary routes: by sequestering the Cas9 apoenzyme, and by re-directing the Cas9 nuclease to transcriptionally silence its own promoter. vsgRNAs also can cooperate with co-encoded anti-CRISPR proteins (Acrs), including AcrIIA25.1 that blocks DNA binding by Cas9 complexed with a standard sgRNA but not with the vsgRNA. We predict that phages evolved vsgRNAs by co-opting and repurposing host-encoded long-form tracrRNAs (tracr-L) responsible for Cas9 auto-repression and a countermeasure to Acrs. Our search also uncovered Cas9-regulating small CRISPR-associated RNAs (scaRNAs), which we predict were inserted upstream of tracrRNAs to form tracr-L but were also co-opted by phages as viral scaRNAs to suppress Cas9 immunity. Finally, we found that vsgRNAs can enable genome editing in mammalian cells, offering a natural guide RNA template for CRISPR technologies. Overall, these findings reveal that bacteriophages devised their own compact sgRNAs tailored to subvert Cas9 immunity, long preceding their rational design to program RNA-guided nucleases.
Open AccessPhage-encoded single-guide RNAs subvert CRISPR-Cas9 immunity
Central to CRISPR technologies is the single-guide RNA (sgRNA), an engineered fusion of a processed CRISPR RNA and tracrRNA that directs Cas9 and many Cas12 nucleases to bind and cleave target DNA. Here, we report the discovery of similarly compact viral sgRNAs (vsgRNAs) encoded by bacteriophages that counteract bacterial CRISPR-Cas9 immunity. vsgRNAs inhibit Cas9 function via two complementary routes: by sequestering the Cas9 apoenzyme, and by re-directing the Cas9 nuclease to transcriptionally silence its own promoter. vsgRNAs also can cooperate with co-encoded anti-CRISPR proteins (Acrs), including AcrIIA25.1 that blocks DNA binding by Cas9 complexed with a standard sgRNA but not with the vsgRNA. We predict that phages evolved vsgRNAs by co-opting and repurposing host-encoded long-form tracrRNAs (tracr-L) responsible for Cas9 auto-repression and a countermeasure to Acrs. Our search also uncovered Cas9-regulating small CRISPR-associated RNAs (scaRNAs), which we predict were inserted upstream of tracrRNAs to form tracr-L but were also co-opted by phages as viral scaRNAs to suppress Cas9 immunity. Finally, we found that vsgRNAs can enable genome editing in mammalian cells, offering a natural guide RNA template for CRISPR technologies. Overall, these findings reveal that bacteriophages devised their own compact sgRNAs tailored to subvert Cas9 immunity, long preceding their rational design to program RNA-guided nucleases.
- Open Access
- 16 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (1) , 001616
Decoding the interconnected splicing patterns of hepatitis B virus and host using large language and deep learning models
Hepatitis B virus (HBV) infection causes one million deaths annually and remains a major driver of hepatocellular carcinoma. Despite its compact 3.2 kb genome, HBV exhibits extensive alternative splicing. HBV splice variants contribute to immune evasion and reduce the likelihood of achieving a functional cure. Here, we show that HBV splicing efficiency – quantified from 279 RNA-sequencing libraries of HBV-associated liver biopsies and cultured cells – correlates more strongly with disease progression than the overall proportion of spliced HBV RNA, the latter of which has been proposed as an emerging biomarker. All HBV splice sites are embedded within protein-coding regions, forming a gene structure distinct from typical host splice sites. To decode the sequence determinants of HBV splicing, we apply SpliceBERT and OpenSpliceAI to 4,706 HBV genomes. These models reveal that HBV splice donor sites share features with host splice donor sites, whereas HBV splice acceptor sites are more cryptic. These patterns likely reflect constraints imposed by HBV’s compact genome, which must accommodate overlapping protein-coding regions. Motif conservation and splicing propensity analyses across HBV genomes reveal context- and genotype-specific splicing patterns, indicating regulation by sequence context. HBV genotypes may have coevolved with their human hosts to exploit suboptimal but spliceable host-like motifs without disrupting their gene structure, supporting mechanisms of viral persistence and immune evasion. This study demonstrates the utility of artificial intelligence in decoding viral splicing patterns and provides a framework for investigating co-transcriptional processes in other clinically important viruses.
- 16 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (1) , 001616
Open AccessDecoding the interconnected splicing patterns of hepatitis B virus and host using large language and deep learning models
Hepatitis B virus (HBV) infection causes one million deaths annually and remains a major driver of hepatocellular carcinoma. Despite its compact 3.2 kb genome, HBV exhibits extensive alternative splicing. HBV splice variants contribute to immune evasion and reduce the likelihood of achieving a functional cure. Here, we show that HBV splicing efficiency – quantified from 279 RNA-sequencing libraries of HBV-associated liver biopsies and cultured cells – correlates more strongly with disease progression than the overall proportion of spliced HBV RNA, the latter of which has been proposed as an emerging biomarker. All HBV splice sites are embedded within protein-coding regions, forming a gene structure distinct from typical host splice sites. To decode the sequence determinants of HBV splicing, we apply SpliceBERT and OpenSpliceAI to 4,706 HBV genomes. These models reveal that HBV splice donor sites share features with host splice donor sites, whereas HBV splice acceptor sites are more cryptic. These patterns likely reflect constraints imposed by HBV’s compact genome, which must accommodate overlapping protein-coding regions. Motif conservation and splicing propensity analyses across HBV genomes reveal context- and genotype-specific splicing patterns, indicating regulation by sequence context. HBV genotypes may have coevolved with their human hosts to exploit suboptimal but spliceable host-like motifs without disrupting their gene structure, supporting mechanisms of viral persistence and immune evasion. This study demonstrates the utility of artificial intelligence in decoding viral splicing patterns and provides a framework for investigating co-transcriptional processes in other clinically important viruses.
- Open Access
Phase separation of mycobacterial Rho factor is associated with acid stress
Rho is a bacterial transcription termination factor that contains additional regions in some species, including many mycobacteria. These additional regions are compositionally biased and are predicted to be intrinsically disordered and associated with Liquid-Liquid Phase Separation (LLPS). However, LLPS has only been experimentally demonstrated for Rho from Bacteroides thetaiotaomicron . Here, we extend a prior bioinformatic analysis of Rho from mycobacterial species, where Rho has additional regions that differ from Rho in B. thetaiotaomicron . We show that Mycolicibacterium smegmatis Rho forms in vitro and in vivo condensates by LLPS, and that LLPS depends upon the additional regions. In vitro , droplet formation for Rho from four mycobacterial species was modulated by the presence of RNA and was observed for the intrinsically disordered regions alone, suggesting that these regions are sufficient for droplet formation. Moreover, Rho phase separation in living M. smegmatis cells occurs during acid stress and may impact cell fitness. This phenotype is due to Rho’s additional regions, since engineered mycobacterial Rho lacking the additional regions does not undergo LLPS. In summary, our results indicate that LLPS is a widespread mechanism in which mycobacterial Rho assembles into condensates, possibly terminating the transcription of different genes, which allows tolerance to stress conditions.
Open AccessPhase separation of mycobacterial Rho factor is associated with acid stress
Rho is a bacterial transcription termination factor that contains additional regions in some species, including many mycobacteria. These additional regions are compositionally biased and are predicted to be intrinsically disordered and associated with Liquid-Liquid Phase Separation (LLPS). However, LLPS has only been experimentally demonstrated for Rho from Bacteroides thetaiotaomicron . Here, we extend a prior bioinformatic analysis of Rho from mycobacterial species, where Rho has additional regions that differ from Rho in B. thetaiotaomicron . We show that Mycolicibacterium smegmatis Rho forms in vitro and in vivo condensates by LLPS, and that LLPS depends upon the additional regions. In vitro , droplet formation for Rho from four mycobacterial species was modulated by the presence of RNA and was observed for the intrinsically disordered regions alone, suggesting that these regions are sufficient for droplet formation. Moreover, Rho phase separation in living M. smegmatis cells occurs during acid stress and may impact cell fitness. This phenotype is due to Rho’s additional regions, since engineered mycobacterial Rho lacking the additional regions does not undergo LLPS. In summary, our results indicate that LLPS is a widespread mechanism in which mycobacterial Rho assembles into condensates, possibly terminating the transcription of different genes, which allows tolerance to stress conditions.
- Open Access
Decoding the interconnected splicing patterns of hepatitis B virus and host using large language and deep learning models
Hepatitis B virus (HBV) infection causes approximately one million deaths annually and remains a major driver of hepatocellular carcinoma. Despite its compact 3.2-kb genome, HBV exhibits extensive alternative splicing. Functionally, HBV splice variants contribute to immune evasion and reduce the likelihood of achieving a functional cure. Here, we show that HBV splicing efficiency—quantified from 279 RNA-seq libraries of HBV-associated liver biopsies and cultured cells—correlates more strongly with disease progression than the overall proportion of spliced HBV RNAs, an emerging biomarker. All HBV splice sites are embedded within protein-coding regions, forming a genetic architecture distinct from typical host splice sites. To decode the sequence determinants of HBV splicing, we apply transformer-based and deep learning models to 4,707 HBV genomes. These models reveal that more highly used HBV splice sites are more conserved and share features with host splice sites that are less frequently used but still functional. This similarity likely reflects constraints imposed by HBV’s compact genome, which must accommodate overlapping protein-coding regions. HBV may have evolved to exploit suboptimal but spliceable host-like motifs without disrupting its genetic architecture. Further analysis of splicing propensity across HBV genomes reveals genotype-specific patterns, indicating regulation by sequence context in a site- and genotype-dependent manner. HBV genotypes may have coevolved with their human hosts to fine-tune splicing through host-like features, supporting mechanisms of viral persistence and immune evasion. This study demonstrates the utility of AI in decoding viral splicing architectures and provides a framework for investigating co-transcriptional processes in other clinically important viruses. Impact Statement: Hepatitis B virus (HBV) is a major global health concern, causing 1.1 million deaths in 2022 and 1.2 million new infections each year. It is a leading cause of serious liver conditions, including cirrhosis and liver cancer. Although vaccines can prevent HBV infection, there is currently no cure. HBV produces different types of genetic messages (RNAs), including spliced versions that are processed by the host cell’s machinery. These spliced RNAs help the virus evade the immune system and make it harder for treatments to fully clear the infection. In this study, we analysed 279 HBV samples from liver tissues and lab-grown cells and found that the efficiency of host-mediated splicing of viral RNA reflects the severity of disease. Using advanced artificial intelligence tools, we mapped the splicing patterns in both the virus and human host, and investigated over 4,700 HBV genomes. We discovered that HBV splice sites resemble host splice sites that are used less frequently but remain functional, suggesting the virus has evolved RNA sequences that are compatible with the host cell’s splicing machinery while accommodating its compact genome. Insights into this viral adaptation may help researchers identify new biomarkers for disease severity and develop therapeutic strategies that disrupt the virus’s ability to exploit the host cell’s machinery. Data Summary: The raw RNA-sequencing (RNA-seq) libraries analysed in this study were previously published and are available in the Gene Expression Omnibus under accession number GSE155983. These libraries form part of a curated collection of 279 RNA-seq datasets derived from HBV-associated liver biopsy tissues and cultured cells. Further details and metadata are available in the associated GitHub repository: https://github.com/lcscs12345/HBV_splicing_paper_2025 .
Open AccessDecoding the interconnected splicing patterns of hepatitis B virus and host using large language and deep learning models
Hepatitis B virus (HBV) infection causes approximately one million deaths annually and remains a major driver of hepatocellular carcinoma. Despite its compact 3.2-kb genome, HBV exhibits extensive alternative splicing. Functionally, HBV splice variants contribute to immune evasion and reduce the likelihood of achieving a functional cure. Here, we show that HBV splicing efficiency—quantified from 279 RNA-seq libraries of HBV-associated liver biopsies and cultured cells—correlates more strongly with disease progression than the overall proportion of spliced HBV RNAs, an emerging biomarker. All HBV splice sites are embedded within protein-coding regions, forming a genetic architecture distinct from typical host splice sites. To decode the sequence determinants of HBV splicing, we apply transformer-based and deep learning models to 4,707 HBV genomes. These models reveal that more highly used HBV splice sites are more conserved and share features with host splice sites that are less frequently used but still functional. This similarity likely reflects constraints imposed by HBV’s compact genome, which must accommodate overlapping protein-coding regions. HBV may have evolved to exploit suboptimal but spliceable host-like motifs without disrupting its genetic architecture. Further analysis of splicing propensity across HBV genomes reveals genotype-specific patterns, indicating regulation by sequence context in a site- and genotype-dependent manner. HBV genotypes may have coevolved with their human hosts to fine-tune splicing through host-like features, supporting mechanisms of viral persistence and immune evasion. This study demonstrates the utility of AI in decoding viral splicing architectures and provides a framework for investigating co-transcriptional processes in other clinically important viruses. Impact Statement: Hepatitis B virus (HBV) is a major global health concern, causing 1.1 million deaths in 2022 and 1.2 million new infections each year. It is a leading cause of serious liver conditions, including cirrhosis and liver cancer. Although vaccines can prevent HBV infection, there is currently no cure. HBV produces different types of genetic messages (RNAs), including spliced versions that are processed by the host cell’s machinery. These spliced RNAs help the virus evade the immune system and make it harder for treatments to fully clear the infection. In this study, we analysed 279 HBV samples from liver tissues and lab-grown cells and found that the efficiency of host-mediated splicing of viral RNA reflects the severity of disease. Using advanced artificial intelligence tools, we mapped the splicing patterns in both the virus and human host, and investigated over 4,700 HBV genomes. We discovered that HBV splice sites resemble host splice sites that are used less frequently but remain functional, suggesting the virus has evolved RNA sequences that are compatible with the host cell’s splicing machinery while accommodating its compact genome. Insights into this viral adaptation may help researchers identify new biomarkers for disease severity and develop therapeutic strategies that disrupt the virus’s ability to exploit the host cell’s machinery. Data Summary: The raw RNA-sequencing (RNA-seq) libraries analysed in this study were previously published and are available in the Gene Expression Omnibus under accession number GSE155983. These libraries form part of a curated collection of 279 RNA-seq datasets derived from HBV-associated liver biopsy tissues and cultured cells. Further details and metadata are available in the associated GitHub repository: https://github.com/lcscs12345/HBV_splicing_paper_2025 .
- Open Access
RIBOSS detects novel translational events by combining long- and short-read transcriptome and translatome profiling
Ribosome profiling is a high-throughput sequencing technique that captures the positions of translating ribosomes on RNAs. Recent advancements in ribosome profiling include achieving highly-phased ribosome footprints for plant translatomes and more recently for bacterial translatomes. This substantially increases the specificity of detecting open reading frames (ORFs) that can be translated, such as small ORFs located upstream and downstream of the annotated ORFs. However, most genomes (e.g. bacterial genomes) lack the annotations for the transcription start and termination sites. This hinders the systematic discovery of novel ORFs in the ‘untranslated’ regions in ribosome profiling data. Here we develop a new computational pipeline called RIBOSS. We use RIBOSS to leverage long-read and short-read data for de novo transcriptome assembly, and highly-phased ribosome profiling data for detecting novel translational events in the newly assembled transcriptome. We demonstrate the capability of RIBOSS using recently published metatranscriptome and translatome data for Salmonella enterica serovar Typhimurium. The RIBOSS Python modules are versatile and can be used to analyse prokaryotic or eukaryotic data. In sum, RIBOSS is the first computational pipeline to integrate long- and short-read sequencing technologies to investigate translation. RIBOSS is freely available at https://github.com/lcscs12345/riboss .
Open AccessRIBOSS detects novel translational events by combining long- and short-read transcriptome and translatome profiling
Ribosome profiling is a high-throughput sequencing technique that captures the positions of translating ribosomes on RNAs. Recent advancements in ribosome profiling include achieving highly-phased ribosome footprints for plant translatomes and more recently for bacterial translatomes. This substantially increases the specificity of detecting open reading frames (ORFs) that can be translated, such as small ORFs located upstream and downstream of the annotated ORFs. However, most genomes (e.g. bacterial genomes) lack the annotations for the transcription start and termination sites. This hinders the systematic discovery of novel ORFs in the ‘untranslated’ regions in ribosome profiling data. Here we develop a new computational pipeline called RIBOSS. We use RIBOSS to leverage long-read and short-read data for de novo transcriptome assembly, and highly-phased ribosome profiling data for detecting novel translational events in the newly assembled transcriptome. We demonstrate the capability of RIBOSS using recently published metatranscriptome and translatome data for Salmonella enterica serovar Typhimurium. The RIBOSS Python modules are versatile and can be used to analyse prokaryotic or eukaryotic data. In sum, RIBOSS is the first computational pipeline to integrate long- and short-read sequencing technologies to investigate translation. RIBOSS is freely available at https://github.com/lcscs12345/riboss .
- 10 July 2024
- Published by Springer Nature in Nature
- Vol. 631 (8021) , 670-677
Phage anti-CRISPR control by an RNA- and DNA-binding helix–turn–helix protein
In all organisms, regulation of gene expression must be adjusted to meet cellular requirements and frequently involves helix–turn–helix (HTH) domain proteins1. For instance, in the arms race between bacteria and bacteriophages, rapid expression of phage anti-CRISPR (acr) genes upon infection enables evasion from CRISPR–Cas defence; transcription is then repressed by an HTH-domain-containing anti-CRISPR-associated (Aca) protein, probably to reduce fitness costs from excessive expression2,3,4,5. However, how a single HTH regulator adjusts anti-CRISPR production to cope with increasing phage genome copies and accumulating acr mRNA is unknown. Here we show that the HTH domain of the regulator Aca2, in addition to repressing Acr synthesis transcriptionally through DNA binding, inhibits translation of mRNAs by binding conserved RNA stem-loops and blocking ribosome access. The cryo-electron microscopy structure of the approximately 40 kDa Aca2–RNA complex demonstrates how the versatile HTH domain specifically discriminates RNA from DNA binding sites. These combined regulatory modes are widespread in the Aca2 family and facilitate CRISPR–Cas inhibition in the face of rapid phage DNA replication without toxic acr overexpression. Given the ubiquity of HTH-domain-containing proteins, it is anticipated that many more of them elicit regulatory control by dual DNA and RNA binding.
- 10 July 2024
- Published by Springer Nature in Nature
- Vol. 631 (8021) , 670-677
Phage anti-CRISPR control by an RNA- and DNA-binding helix–turn–helix protein
In all organisms, regulation of gene expression must be adjusted to meet cellular requirements and frequently involves helix–turn–helix (HTH) domain proteins1. For instance, in the arms race between bacteria and bacteriophages, rapid expression of phage anti-CRISPR (acr) genes upon infection enables evasion from CRISPR–Cas defence; transcription is then repressed by an HTH-domain-containing anti-CRISPR-associated (Aca) protein, probably to reduce fitness costs from excessive expression2,3,4,5. However, how a single HTH regulator adjusts anti-CRISPR production to cope with increasing phage genome copies and accumulating acr mRNA is unknown. Here we show that the HTH domain of the regulator Aca2, in addition to repressing Acr synthesis transcriptionally through DNA binding, inhibits translation of mRNAs by binding conserved RNA stem-loops and blocking ribosome access. The cryo-electron microscopy structure of the approximately 40 kDa Aca2–RNA complex demonstrates how the versatile HTH domain specifically discriminates RNA from DNA binding sites. These combined regulatory modes are widespread in the Aca2 family and facilitate CRISPR–Cas inhibition in the face of rapid phage DNA replication without toxic acr overexpression. Given the ubiquity of HTH-domain-containing proteins, it is anticipated that many more of them elicit regulatory control by dual DNA and RNA binding.
- Open Access
- 5 July 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (15) , 8979-8997
Diversification of the Rho transcription termination factor in bacteria
Correct termination of transcription is essential for gene expression. In bacteria, factor-dependent termination relies on the Rho factor, that classically has three conserved domains. Some bacteria also have a functional insertion region. However, the variation in Rho structure among bacteria has not been analyzed in detail. This study determines the distribution, sequence conservation, and predicted features of Rho factors with diverse domain architectures by analyzing 2730 bacterial genomes. About half (49.8%) of the species analyzed have the typical Escherichia coli like Rho while most of the other species (39.8%) have diverse, atypical forms of Rho. Besides conservation of the main domains, we describe a duplicated RNA-binding domain present in specific species and novel variations in the bicyclomycin binding pocket. The additional regions observed in Rho proteins exhibit remarkable diversity. Commonly, however, they have exceptional amino acid compositions and are predicted to be intrinsically disordered, to undergo phase separation, or have prion-like behavior. Phase separation has recently been shown to play roles in Rho function and bacterial fitness during harsh conditions in one species and this study suggests a more widespread role. In conclusion, diverse atypical Rho factors are broadly distributed among bacteria, suggesting additional cellular roles.
- 5 July 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (15) , 8979-8997
Open AccessDiversification of the Rho transcription termination factor in bacteria
Correct termination of transcription is essential for gene expression. In bacteria, factor-dependent termination relies on the Rho factor, that classically has three conserved domains. Some bacteria also have a functional insertion region. However, the variation in Rho structure among bacteria has not been analyzed in detail. This study determines the distribution, sequence conservation, and predicted features of Rho factors with diverse domain architectures by analyzing 2730 bacterial genomes. About half (49.8%) of the species analyzed have the typical Escherichia coli like Rho while most of the other species (39.8%) have diverse, atypical forms of Rho. Besides conservation of the main domains, we describe a duplicated RNA-binding domain present in specific species and novel variations in the bicyclomycin binding pocket. The additional regions observed in Rho proteins exhibit remarkable diversity. Commonly, however, they have exceptional amino acid compositions and are predicted to be intrinsically disordered, to undergo phase separation, or have prion-like behavior. Phase separation has recently been shown to play roles in Rho function and bacterial fitness during harsh conditions in one species and this study suggests a more widespread role. In conclusion, diverse atypical Rho factors are broadly distributed among bacteria, suggesting additional cellular roles.
- Open Access
- 1 July 2024
- Published by Elsevier in Fungal Biology Reviews
- Vol. 49
Navigating the labyrinth – Searching for mechanistic clues to explain the evolution of sequestrate Agaricales with labyrinthine internal chambers
- 1 July 2024
- Published by Elsevier in Fungal Biology Reviews
- Vol. 49
Open AccessNavigating the labyrinth – Searching for mechanistic clues to explain the evolution of sequestrate Agaricales with labyrinthine internal chambers